Patient characteristics and Notch1 immunohistochemical stain scores
Patient no. . | Age, y . | Sex . | Diagnosis . | Stage . | Notch status in tumor cells . |
---|---|---|---|---|---|
1 | 75 | Female | MF patch | IB | Negative |
2 | 44 | Female | MF patch | IB | Negative |
3 | 67 | Male | MF patch | IB | Negative |
4 | 59 | Male | MF patch | IB | Negative |
5 | 59 | Male | MF patch | IB | Negative |
6 | 55 | Female | MF patch | IB | > 50% |
7 | 44 | Female | MF plaque | I | Negative |
8 | 57 | Male | MF plaque | IB | Negative |
9 | 80 | Female | MF plaque | I | Negative |
10 | 77 | Male | MF erythrodermic | IIIA | Negative |
11 | 80 | Male | MF plaque | IB | Negative |
12 | 49 | Female | MF plaque | IB | Negative |
13 | 33 | Male | MF plaque | IA | Negative |
14 | 56 | Male | MF plaque | I | > 10% - < 50% |
15 | 44 | Male | MF folliculotropic | IB | > 10% - < 50% |
16 | 33 | Male | MF plaque | IA | > 50% |
17 | 74 | Female | MF tumor | IIB | Negative |
18 | 84 | Female | MF tumor | IIB | > 50% |
19 | 50 | Female | MF tumor | IVB | > 50% |
20 | 70 | Female | MF tumor | IIB | > 50% |
21 | 82 | Male | MF tumor | IIB | > 50% |
22 | 66 | Male | MF tumor | IIB | > 50% |
23 | 57 | Female | MF tumor | IIB | > 50% |
24 | 79 | Male | MF tumor | IIB | > 50% |
25 | 58 | Male | MF tumor | IIB | > 50% |
26 | 84 | Female | MF transformed | IIB | Negative |
27 | 83 | Male | MF transformed | IIB | Negative |
28 | 71 | Male | MF transformed | IIB | Negative |
29 | 77 | Male | MF transformed | II | > 10% - < 50% |
30 | 63 | Male | MF transformed | IIB | > 10% - < 50% |
31 | 57 | Male | MF transformed | IVB | > 10% - < 50% |
32 | 51 | Female | MF transformed | IVB | > 10% - < 50% (same patient as patient 19) |
33 | 61 | Female | MF transformed | IVA | > 50% |
34 | 67 | Male | MF transformed | IIA | > 50% |
35 | 77 | Male | MF transformed | IVA | > 50% |
36 | 68 | Male | SS | IVA | Negative |
37 | 71 | Male | SS | IVB | Negative |
38 | 72 | Male | SS | IVA | Negative |
39 | 73 | Male | SS | IVB | > 50% |
40 | 65 | Male | SS | IV | > 50% |
Patient no. . | Age, y . | Sex . | Diagnosis . | Stage . | Notch status in tumor cells . |
---|---|---|---|---|---|
1 | 75 | Female | MF patch | IB | Negative |
2 | 44 | Female | MF patch | IB | Negative |
3 | 67 | Male | MF patch | IB | Negative |
4 | 59 | Male | MF patch | IB | Negative |
5 | 59 | Male | MF patch | IB | Negative |
6 | 55 | Female | MF patch | IB | > 50% |
7 | 44 | Female | MF plaque | I | Negative |
8 | 57 | Male | MF plaque | IB | Negative |
9 | 80 | Female | MF plaque | I | Negative |
10 | 77 | Male | MF erythrodermic | IIIA | Negative |
11 | 80 | Male | MF plaque | IB | Negative |
12 | 49 | Female | MF plaque | IB | Negative |
13 | 33 | Male | MF plaque | IA | Negative |
14 | 56 | Male | MF plaque | I | > 10% - < 50% |
15 | 44 | Male | MF folliculotropic | IB | > 10% - < 50% |
16 | 33 | Male | MF plaque | IA | > 50% |
17 | 74 | Female | MF tumor | IIB | Negative |
18 | 84 | Female | MF tumor | IIB | > 50% |
19 | 50 | Female | MF tumor | IVB | > 50% |
20 | 70 | Female | MF tumor | IIB | > 50% |
21 | 82 | Male | MF tumor | IIB | > 50% |
22 | 66 | Male | MF tumor | IIB | > 50% |
23 | 57 | Female | MF tumor | IIB | > 50% |
24 | 79 | Male | MF tumor | IIB | > 50% |
25 | 58 | Male | MF tumor | IIB | > 50% |
26 | 84 | Female | MF transformed | IIB | Negative |
27 | 83 | Male | MF transformed | IIB | Negative |
28 | 71 | Male | MF transformed | IIB | Negative |
29 | 77 | Male | MF transformed | II | > 10% - < 50% |
30 | 63 | Male | MF transformed | IIB | > 10% - < 50% |
31 | 57 | Male | MF transformed | IVB | > 10% - < 50% |
32 | 51 | Female | MF transformed | IVB | > 10% - < 50% (same patient as patient 19) |
33 | 61 | Female | MF transformed | IVA | > 50% |
34 | 67 | Male | MF transformed | IIA | > 50% |
35 | 77 | Male | MF transformed | IVA | > 50% |
36 | 68 | Male | SS | IVA | Negative |
37 | 71 | Male | SS | IVB | Negative |
38 | 72 | Male | SS | IVA | Negative |
39 | 73 | Male | SS | IVB | > 50% |
40 | 65 | Male | SS | IV | > 50% |
Negative indicates that < 10% of tumor cells are labeled in Notch1.